Home » Newsletters » BioWorld Science

BioWorld Science

March 22, 2010

View Archived Issues

Roche presents novel DP2 receptor antagonists

Boehringer Ingelheim presents novel 11-beta-HSD1 inhibitors

Takeda claims novel H+/K+-ATPase proton pump inhibitors

Boehringer Ingelheim claims new Mnk1 and/or Mnk2 inhibitors

Takeda identifies novel Polo-like kinase inhibitors

Vorinostat exhibits safety and tolerability in phase II trial in advanced renal cell carcinoma

Clinical phase I/II data on TAK-700 in metastatic CRPC disclosed

Chugai seeks Japanese approval for Herceptin in combination with Xeloda for gastric cancer

Cilengitide does not exhibit antitumor activity in phase II nonmetastatic CRPC trial

Paclitaxel nanoparticles potent as second-line therapy in phase II trial in metastatic UC

Tripep changes name to ChronTech Pharma

A.P. Pharma receives FDA complete response letter for APF-530

Cytokinetics opens phase IIa CK-2017357 trial in ALS

GlaxoSmithKline begins phase III Relovair program in asthma

Synergy begins phase IIa trial of SP-304 in patients with constipation

Takeda withdraws MAA for prolonged-release Competact for type 2 diabetes

PPD and Southern Research Institute collaborate on flu vaccine research services

OSI receives positive opinion on Tarceva for NSCLC from European health authorities

Agennix raises funds for continued talactoferrin development

AstraZeneca and Torrent Pharmaceuticals enter into branded generics agreement / News in Context

Helix BioPharma nears completion phase II trial of topical interferon alpha-2b for anogenital warts

Novel mu opioid receptor inverse agonist in phase I development by GSK for obesity

Roche submits MAA with EMA to extend MabThera label

FDA issues warning for highest approved dose of cholesterol-lowering Zocor

European orphan drug designation for Allon Therapeutics' davunetide in PSP

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...